Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
BG Medicine Inc
BGMDCurrent price
0.0001 USD
0 USD (0.00%)
Last closed
0.0001 USD
Company
www.bg-medicine.com
ISIN
US08861T2069
Sector
Healthcare
Industry
Medical Instruments & Supplies
Exchange
PINK
Capitalization
545 969 USD
Yield for 12 month
0.00 %
1Y
3Y
5Y
10Y
15Y
BGMD
BG Medicine, Inc. engages in the development and commercialization of diagnostic products used to guide the patients suffering from heart failure and related disorders in the United States. The company offers BGM Galectin-3 Test, an in vitro diagnostic device that measures galectin-3 in serum or plasma by enzyme linked immunosorbent assay on a microtiter plate platform; and CardioSCORE Test, a multi-analyte biomarker-based blood test used for the assessment of near-term risk of atherothrombotic cardiovascular events, such as heart attack and ischemic stroke. It has license, development, and commercialization agreements with Abbott Laboratories, bioMérieux SA, Siemens Healthcare Diagnostics Inc., and Alere Inc. for the automated instrument versions of galectin-3 test; and a strategic collaboration with Abbott Laboratories to develop and commercialize galectin-3 assay kits, and related control kits and calibrators. The company was formerly known as Beyond Genomics, Inc. and changed its name to BG Medicine, Inc. in October 2004. BG Medicine, Inc. was founded in 2000 and is headquartered in Waltham, Massachusetts. Address: 303 Wyman Street, Waltham, MA, United States, 02451
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
1.4 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
+290 000 USD
Last Quarter
+334 000 USD
Current Year
–
Last Year
–
Current Quarter
+208 000 USD
Last Quarter
+231 000 USD
Key Figures BGMD
1 year
3 years
5 years
10 years
EBITDA
-4 386 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-75.95 %
PEG Ratio
–
Return On Equity TTM
-902.64 %
Wall Street Target Price
1.4 USD
Revenue TTM
1 566 000 USD
Book Value
-0.18 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-47.7 %
Dividend Yield
–
Gross Profit TTM
1 061 000 USD
Earnings per share
–
Diluted Eps TTM
–
Most Recent Quarter
IV 2015
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics BGMD
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History BGMD
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:4
Payout Ratio
–
Last Split Date
09.07.2015
Dividend Date
–
Stock Valuation BGMD
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
0.3486
Price Sales TTM
0.3486
Enterprise Value EBITDA
-0.108
Price Book MRQ
–
Financials BGMD
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators BGMD
For 52 weeks
–
0.0001 USD
50 Day MA
0.0001 USD
Shares Short Prior Month
380 493
200 Day MA
0.0001 USD
Short Ratio
2.66
Shares Short
630 048
Short Percent
10.01 %
BeatStart